Zaltrap Европейски съюз - словашки - EMA (European Medicines Agency)

zaltrap

sanofi winthrop industrie - aflibercept - kolorektálne novotvary - antineoplastické činidlá - liečba metastatického kolorektálneho karcinómu (mcrc).

Dupixent Европейски съюз - словашки - EMA (European Medicines Agency)

dupixent

sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - liečivá na dermatitídu okrem kortikosteroidov - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

Novalgin 500 mg Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

novalgin 500 mg

opella healthcare slovakia s.r.o., slovensko - metamizol, sodná soľ - 07 - analgetica, antipyretica

TRITACE 1,25 Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

tritace 1,25

sanofi winthrop industrie, francúzsko - ramipril - 58 - hypotensiva

TRITACE 2,5 Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

tritace 2,5

sanofi winthrop industrie, francúzsko - ramipril - 58 - hypotensiva

TRITACE 5 Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

tritace 5

sanofi winthrop industrie, francúzsko - ramipril - 58 - hypotensiva

Tritazide 5 mg/25 mg Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

tritazide 5 mg/25 mg

sanofi winthrop industrie, francúzsko - ramipril a diuretiká - 58 - hypotensiva

TRITACE 10 Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

tritace 10

sanofi winthrop industrie, francúzsko - ramipril - 58 - hypotensiva

Metamilan 500 mg tablety Словакия - словашки - ŠÚKL (Štátny ústav pre kontrolu liečiv)

metamilan 500 mg tablety

g.l. pharma gmbh, rakúsko - metamizol, sodná soľ - 07 - analgetica, antipyretica